Single-Cell RNA Sequencing and Network Pharmacology Reveal the Potential Role of Oxidative Phosphorylation
Jie-Jie Niu1, Long Wang2, Jia-Chen Qi1
1Department of Pain, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Background:
Chronic tendon injuries, characterized by persistent pain, reduced flexibility, and impaired function, pose a significant clinical challenge. Current therapeutic strategies for these injuries are limited. This study highlighted the crucial role of OXPHOS in maintaining tendon homeostasis and suggested potential therapeutic strategies targeting the OXPHOS pathway.
Method:
This study utilized both bulk-sequencing (bulk-seq) and single-cell RNA sequencing (scRNA-seq) to analyze the heterogeneity in tenocytes, vascular endothelial cells, tendon-derived stem cells, adipocytes, and neurons from both non-lesional and lesional tendons. Key oxidative phosphorylation (OXPHOS)-related genes, such as COX15, COX4I1, COX5B, COX7A1, COX8A, NDUFA12, NDUFA5, NDUFB10, NDUFB3, NDUFC1, NDUFS1, and NDUFS4, were found to be significantly downregulated in lesional tendons compared with non-lesional ones, indicating impaired energy metabolism. This reduction in OXPHOS activity may contribute to increased necroptosis in chronic tendon injuries. Furthermore, bisphenol A and valproic acid were found to activate OXPHOS-related genes.
Results:
The findings highlighted the crucial role of OXPHOS in maintaining tendon homeostasis and demonstrated potential therapeutic strategies targeting the OXPHOS pathway, such as bisphenol A and valproic acid, to enhance healing in chronic tendon conditions.
Conclusion:
The crucial role of OXPHOS in maintaining tendon homeostasis underscores its potential as a therapeutic target, reflecting that strategies aimed at modulating the OXPHOS pathway may provide promising treatment options. Chronic tendon injuries present a major clinical challenge with limited treatments. This study investigated the molecular mechanisms underlying these injuries using bulk and single-cell RNA sequencing. We identified significant downregulation of oxidative phosphorylation (OXPHOS)-related genes in lesional tendons across multiple cell types, contributing to increased necroptosis. In vitro experiments and molecular docking revealed that valproic acid activates OXPHOS and inhibits necroptosis. These findings highlight the critical role of mitochondrial function in tendon homeostasis and suggest valproic acid as a promising therapeutic candidate for treating chronic tendon injuries by restoring OXPHOS activity.
Insights
Chronic tendon injuries involve impaired energy metabolism due to reduced oxidative phosphorylation (OXPHOS). Valproic acid shows promise for treating these conditions by restoring OXPHOS and inhibiting cell death.
Area of Science:
- Mitochondrial biology
- Cellular metabolism
- Regenerative medicine
Background:
- Chronic tendon injuries present a significant clinical challenge with limited effective treatments.
- These injuries are characterized by persistent pain, reduced flexibility, and impaired function.
- Oxidative phosphorylation (OXPHOS) plays a critical role in maintaining tendon homeostasis.
Purpose of the Study:
- To investigate the molecular mechanisms underlying chronic tendon injuries.
- To identify key cellular pathways and potential therapeutic targets.
- To evaluate the role of OXPHOS in tendon health and disease.
Main Methods:
- Utilized bulk and single-cell RNA sequencing (scRNA-seq) to analyze cell heterogeneity in lesional and non-lesional tendons.
- Examined tenocytes, vascular endothelial cells, tendon-derived stem cells, adipocytes, and neurons.
- Investigated the effects of bisphenol A and valproic acid on OXPHOS-related genes.
Main Results:
- Significant downregulation of key OXPHOS-related genes was observed in lesional tendons across multiple cell types.
- Reduced OXPHOS activity correlates with increased necroptosis in chronic tendon injuries.
- Bisphenol A and valproic acid were identified as activators of OXPHOS-related genes.
Conclusions:
- OXPHOS is crucial for maintaining tendon homeostasis and represents a potential therapeutic target.
- Valproic acid activates OXPHOS and inhibits necroptosis in vitro, suggesting its potential as a therapeutic agent for chronic tendon injuries.
- Restoring OXPHOS activity may offer a promising strategy for enhancing tendon healing.
Related Concept Videos
X-Inactivation
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Sequence Networks of Rotating Machines
Zero-sequence current induces a voltage drop across the generator's neutral impedance and other...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
RNA Stability


